These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9634073)

  • 41. Fine and coarse controls of genetic recombination.
    Simchen G; Stamberg J
    Nature; 1969 Apr; 222(5191):329-32. PubMed ID: 4889487
    [No Abstract]   [Full Text] [Related]  

  • 42. Complex elementary movements of humans--the anthropological approach of Ferenc Katona.
    Mandujano M; Muñoz-Ledo P; Sanchez-Perez C
    Ideggyogy Sz; 2005 Sep; 58(9-10):337-42. PubMed ID: 16252895
    [No Abstract]   [Full Text] [Related]  

  • 43. A trip down memory lane with Retrovirology.
    Benkirane M; Berkhout B; Borrow P; Fassati A; Fujii M; Garcia-Martinez JV; Margolis D; Nijhuis M; Parent L; Strebel K; Venter F; Kirchhoff F; Lever A; Ross S; Mak J
    Retrovirology; 2019 Aug; 16(1):22. PubMed ID: 31434571
    [No Abstract]   [Full Text] [Related]  

  • 44. The viral theory of schizophrenia.
    Crow TJ
    Br J Psychiatry; 1988 Oct; 153():564-6. PubMed ID: 3250700
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative pathogenesis of epsilonretroviruses.
    Holzschu D; Lapierre LA; Lairmore MD
    J Virol; 2003 Dec; 77(23):12385-91. PubMed ID: 14610162
    [No Abstract]   [Full Text] [Related]  

  • 46. The rate of polygenic mutation.
    Lynch M
    Genet Res; 1988 Apr; 51(2):137-48. PubMed ID: 3410317
    [No Abstract]   [Full Text] [Related]  

  • 47. Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis.
    Nao N; Okagawa T; Nojiri N; Konnai S; Shimakura H; Tominaga M; Yoshida-Furihata H; Nishiyama E; Matsudaira T; Maekawa N; Murata S; Muramatsu M; Ohashi K; Saito M
    Arch Virol; 2024 Feb; 169(3):47. PubMed ID: 38366081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages.
    Ravi V; Shamim U; Khan MA; Swaminathan A; Mishra P; Singh R; Bharali P; Chauhan NS; Pandey R
    Front Med (Lausanne); 2023; 10():1294699. PubMed ID: 38288302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adaptation of HIV-1/HIV-2 Chimeras with Defects in Genome Packaging and Viral Replication.
    Rawson JMO; Nikolaitchik OA; Yoo JA; Somoulay X; Brown MA; Mbuntcha Bogni FS; Pathak VK; Soheilian F; Slack RL; Sarafianos SG; Hu WS
    mBio; 2022 Oct; 13(5):e0222022. PubMed ID: 36036631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.
    Ghosh S; Brown AM; Jenkins C; Campbell K
    Appl Biosaf; 2020 Mar; 25(1):7-18. PubMed ID: 36033383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts.
    Umviligihozo G; Muok E; Nyirimihigo Gisa E; Xu R; Dilernia D; Herard K; Song H; Qin Q; Bizimana J; Farmer P; Hare J; Gilmour J; Allen S; Karita E; Hunter E; Yue L
    Front Microbiol; 2021; 12():734929. PubMed ID: 34690973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview.
    Giovanetti M; Ciccozzi M; Parolin C; Borsetti A
    Pathogens; 2020 Dec; 9(12):. PubMed ID: 33371264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced enzyme kinetics of reverse transcriptase variants cloned from animals infected with SIVmac239 lacking viral protein X.
    Coggins SA; Kim DH; Schinazi RF; Desrosier RC; Kim B
    J Biol Chem; 2020 Dec; 295(50):16975-16986. PubMed ID: 33008888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of Expression and Latency in BLV and HTLV.
    Pluta A; Jaworski JP; Douville RN
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992917
    [No Abstract]   [Full Text] [Related]  

  • 55. The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance.
    Yeo JY; Goh GR; Su CT; Gan SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32182845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance.
    Skittrall JP; Ingemarsdotter CK; Gog JR; Lever AML
    PLoS Comput Biol; 2019 Sep; 15(9):e1007345. PubMed ID: 31545786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
    Ganusov VV
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extremely High Mutation Rate of HIV-1 In Vivo.
    Cuevas JM; Geller R; Garijo R; López-Aldeguer J; Sanjuán R
    PLoS Biol; 2015; 13(9):e1002251. PubMed ID: 26375597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current perspectives on HIV-1 antiretroviral drug resistance.
    Iyidogan P; Anderson KS
    Viruses; 2014 Oct; 6(10):4095-139. PubMed ID: 25341668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
    Chernobrovkin AL; Zubarev RA
    PLoS One; 2014; 9(3):e91433. PubMed ID: 24618588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.